Viking Global Investors »

Oruka Therapeutics shares owned by Viking Global Investors

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Viking Global Investors from 13F filings

Historical chart of Viking Global Investors investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Viking Global Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Viking Global Investors

Quarter filed Position value Share count Share price at filing
2025-09-30 $51M 2.7M 19.23

More positions owned by Viking Global Investors

PNC Financial Services (PNC)
JPMorgan Chase & Co. (JPM)
Charles Schwab Corporation (SCHW)
Capital One Financial (COF)
Microsoft Corporation (MSFT)
Walt Disney Company (DIS)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
McDonald's Corporation (MCD)
Fortive (FTV)
Air Products & Chemicals (APD)
Sherwin-Williams Company (SHW)
Visa Com Cl A (V)
Bridgebio Pharma (BBIO)
General Motors Company (GM)
Carvana Cl A (CVNA)

View all positions for Viking Global Investors

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
Viking Global Investors
Deep Track Capital
BlackRock
Rtw Investments
Vanguard Group
Commodore Capital
Braidwell
venBio Select Advisor
Perceptive Advisors
Franklin Resources
Point72 Asset Management
Polar Capital Holdings

View all funds holding Oruka Therapeutics